New insider activity at Cencora ( (COR) ) has taken place on February 25, 2025.
EVP Silvana Battaglia recently sold 5,000 shares of Cencora stock, amounting to a total transaction value of $1,211,200.
Recent Updates on COR stock
Cencora, Inc. has reported strong financial results for Q1 of fiscal year 2025, with a 13% increase in revenue and a 14% rise in adjusted EPS, driven by the U.S. healthcare solutions segment’s performance and strategic acquisitions like Retina Consultants of America. The company raised its full-year EPS guidance, reflecting confidence in its growth trajectory. However, challenges such as a decreased gross profit margin due to low-margin GLP-1 product sales and negative free cash flow were noted. Analysts have raised price targets for Cencora, citing its ability to capitalize on industry-wide trends and strategic initiatives, despite some international segment headwinds. The company’s focus remains on sustaining growth in key segments and managing cash flow effectively.
More about Cencora
YTD Price Performance: 7.70%
Average Trading Volume: 1,341,843
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: $46.82B